human opn immunoassay (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
human opn immunoassay
Human Opn Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 160 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/quantikine+human+opn+immunoassay/Human+Osteopontin+(OPN)+Quantikine+ELISA+Kit/10__4103_slash_ijh__ijh_93_24-45-17-23
Average 95 stars, based on 160 article reviews
Human Opn Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 160 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/quantikine+human+opn+immunoassay/Human+Osteopontin+(OPN)+Quantikine+ELISA+Kit/10__4103_slash_ijh__ijh_93_24-45-17-23
Average 95 stars, based on 160 article reviews
human opn immunoassay - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Cell Culture:Article Title: Beclin1-induced autophagy abrogates radioresistance of lung cancer cells by suppressing osteopontin. Article Snippet: .. OPN levels from cultured medium were determined by Article Title: The O‑glycosylation mutant osteopontin alters lung cancer cell growth and migration in vitro and in vivo. Article Snippet: .. OPN levels from a cultured medium were then determined via Enzyme-linked Immunosorbent Assay:Article Title: Osteopontin as novel biomarker for reversibility of pressure overload induced left ventricular hypertrophy. Article Snippet: .. OPN was measured using the Article Title: Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica. Article Snippet: Contents lists available at ScienceDirect Journal of Neuroimmunology j ourna l homepage: www.e lsev ie r .com/ locate / jneuro im Short communication Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica Yuko Shimizu a,⁎, Kohei Ota b, Ryotaro Ikeguchi a, Sachiko Kubo a, Chiaki Kabasawa a, Shinichiro Uchiyama a a Department of Neurology, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan b Faculty of Science, Tokyo University of Science, Tokyo, Japan ⁎ Corresponding author at: Department of Neurolo University School of Medicine, 8-1 Kawadacho, Sh Japan.. Tel.. : +81 3 3353 8111x39232; fax: +81 3 52 E-mail address: yshimizu@nij.twmu.ac.jp (Y. Shimizu) 0165-5728/$ – see front matter © 2013 Elsevier B.V. All r http://dx.doi.org/10.1016/j.jneuroim.2013.07.005 a b s t r a c t a r t i c l e i n f o Article history: Received 29 April 2013 Received in revised form 5 July 2013 Accepted 8 July 2013 Keywords: Plasma osteopontin Multiple sclerosis Neuromyelitis optica Disease activity Disease progression Osteopontin (OPN) up-regulates pro-inflammatory cytokines from both T helper type 1 and T helper type 17 cell pathways.Wemeasured plasma OPN levels in Japanesemultiple sclerosis (MS) and neuromyelitis optica (NMO) patients to investigate its value as a potential biomarker of disease activity. Article Title: Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI) Article Snippet: .. OPN was measured using the Clinical Proteomics:Article Title: Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica. Article Snippet: Contents lists available at ScienceDirect Journal of Neuroimmunology j ourna l homepage: www.e lsev ie r .com/ locate / jneuro im Short communication Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica Yuko Shimizu a,⁎, Kohei Ota b, Ryotaro Ikeguchi a, Sachiko Kubo a, Chiaki Kabasawa a, Shinichiro Uchiyama a a Department of Neurology, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan b Faculty of Science, Tokyo University of Science, Tokyo, Japan ⁎ Corresponding author at: Department of Neurolo University School of Medicine, 8-1 Kawadacho, Sh Japan.. Tel.. : +81 3 3353 8111x39232; fax: +81 3 52 E-mail address: yshimizu@nij.twmu.ac.jp (Y. Shimizu) 0165-5728/$ – see front matter © 2013 Elsevier B.V. All r http://dx.doi.org/10.1016/j.jneuroim.2013.07.005 a b s t r a c t a r t i c l e i n f o Article history: Received 29 April 2013 Received in revised form 5 July 2013 Accepted 8 July 2013 Keywords: Plasma osteopontin Multiple sclerosis Neuromyelitis optica Disease activity Disease progression Osteopontin (OPN) up-regulates pro-inflammatory cytokines from both T helper type 1 and T helper type 17 cell pathways.Wemeasured plasma OPN levels in Japanesemultiple sclerosis (MS) and neuromyelitis optica (NMO) patients to investigate its value as a potential biomarker of disease activity. Concentration Assay:Article Title: Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica. Article Snippet: Contents lists available at ScienceDirect Journal of Neuroimmunology j ourna l homepage: www.e lsev ie r .com/ locate / jneuro im Short communication Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica Yuko Shimizu a,⁎, Kohei Ota b, Ryotaro Ikeguchi a, Sachiko Kubo a, Chiaki Kabasawa a, Shinichiro Uchiyama a a Department of Neurology, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan b Faculty of Science, Tokyo University of Science, Tokyo, Japan ⁎ Corresponding author at: Department of Neurolo University School of Medicine, 8-1 Kawadacho, Sh Japan.. Tel.. : +81 3 3353 8111x39232; fax: +81 3 52 E-mail address: yshimizu@nij.twmu.ac.jp (Y. Shimizu) 0165-5728/$ – see front matter © 2013 Elsevier B.V. All r http://dx.doi.org/10.1016/j.jneuroim.2013.07.005 a b s t r a c t a r t i c l e i n f o Article history: Received 29 April 2013 Received in revised form 5 July 2013 Accepted 8 July 2013 Keywords: Plasma osteopontin Multiple sclerosis Neuromyelitis optica Disease activity Disease progression Osteopontin (OPN) up-regulates pro-inflammatory cytokines from both T helper type 1 and T helper type 17 cell pathways.Wemeasured plasma OPN levels in Japanesemultiple sclerosis (MS) and neuromyelitis optica (NMO) patients to investigate its value as a potential biomarker of disease activity. |
